Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.

McCormick BB, Sydor A, Akbari A, Fergusson D, Doucette S, Knoll G.

Am J Kidney Dis. 2008 Sep;52(3):454-63. doi: 10.1053/j.ajkd.2008.01.025. Epub 2008 Apr 22. Review.

PMID:
18433957
2.

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD.

Am J Kidney Dis. 2006 Jul;48(1):8-20. Review.

PMID:
16797382
3.

Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis.

Tian ML, Shen Y, Sun ZL, Zha Y.

Int Urol Nephrol. 2015 May;47(5):815-22. doi: 10.1007/s11255-015-0968-2. Epub 2015 Apr 11. Review.

PMID:
25862237
4.

Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis.

Sarafidis PA, Stafylas PC, Georgianos PI, Saratzis AN, Lasaridis AN.

Am J Kidney Dis. 2010 May;55(5):835-47. doi: 10.1053/j.ajkd.2009.11.013. Epub 2010 Jan 29. Review.

PMID:
20110146
5.

The antiproteinuric effects of blood pressure-lowering agents: differences between nondiabetics and diabetics.

de Jong PE, Heeg JE, Apperloo AJ, de Zeeuw D.

J Cardiovasc Pharmacol. 1992;19 Suppl 6:S28-32. Review.

PMID:
1382162
6.

Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.

Sasongko TH, Nagalla S, Ballas SK.

Cochrane Database Syst Rev. 2015 Jun 4;(6):CD009191. doi: 10.1002/14651858.CD009191.pub3. Review.

PMID:
26041152
7.

Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.

Sasongko TH, Nagalla S, Ballas SK.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD009191. doi: 10.1002/14651858.CD009191.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(6):CD009191.

PMID:
23543572
8.

Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes.

Rodríguez-Morán M, Guerrero-Romero F.

Curr Diabetes Rev. 2008 Feb;4(1):55-62. Review.

PMID:
18220696
9.

Statins for improving renal outcomes: a meta-analysis.

Sandhu S, Wiebe N, Fried LF, Tonelli M.

J Am Soc Nephrol. 2006 Jul;17(7):2006-16. Epub 2006 Jun 8. Review.

10.

A review of the potential benefits of pentoxifylline in diabetic and non-diabetic proteinuria.

Badri S, Dashti-Khavidaki S, Lessan-Pezeshki M, Abdollahi M.

J Pharm Pharm Sci. 2011;14(1):128-37. Review.

11.

Meta-analysis: the effect of statins on albuminuria.

Douglas K, O'Malley PG, Jackson JL.

Ann Intern Med. 2006 Jul 18;145(2):117-24. Review.

PMID:
16847294
12.

Pentoxifylline: a potential therapy for chronic kidney disease.

Lin SL, Chen YM, Chiang WC, Tsai TJ, Chen WY.

Nephrology (Carlton). 2004 Aug;9(4):198-204. Review.

PMID:
15363050
13.

Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials.

Cross NB, Webster AC, Masson P, O'connell PJ, Craig JC.

Transplantation. 2009 Jul 15;88(1):7-18. doi: 10.1097/TP.0b013e3181a9e960. Review.

PMID:
19584673
14.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

15.

Emerging therapeutic strategies in diabetic nephropathy.

Ravera M, Re M, Weiss U, Deferrari L, Deferrari G.

J Nephrol. 2007 Nov-Dec;20 Suppl 12:S23-32. Review.

PMID:
18050139
16.

The renoprotective potential of pentoxifylline in chronic kidney disease.

Lin SL, Chiang WC, Chen YM, Lai CF, Tsai TJ, Hsieh BS.

J Chin Med Assoc. 2005 Mar;68(3):99-105. Review.

17.

Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized and observational studies.

Nigwekar SU, Kandula P, Hix JK, Thakar CV.

Am J Kidney Dis. 2009 Sep;54(3):413-23. doi: 10.1053/j.ajkd.2009.01.267. Epub 2009 May 5. Review.

PMID:
19406542
18.

Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence.

Hiremath S, Fergusson D, Doucette S, Mulay AV, Knoll GA.

Am J Transplant. 2007 Oct;7(10):2350-60. Review.

19.

Proteinuria and progression of renal disease: therapeutic implications.

Gansevoort RT, Navis GJ, Wapstra FH, de Jong PE, de Zeeuw D.

Curr Opin Nephrol Hypertens. 1997 Mar;6(2):133-40. Review.

PMID:
9146974
20.

Diabetic nephropathy: the proteinuria hypothesis.

Williams ME.

Am J Nephrol. 2005 Mar-Apr;25(2):77-94. Epub 2005 Mar 3. Review.

Supplemental Content

Support Center